IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q4 2018 Holdings

Filed 2019-02-14 | 6 holdings | $292.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$95.5K8,930,23732.6%
Inflarx NV(IFRX)COMN44821101$64.2K1,764,88821.9%
Solid Biosciences IncCOM83422E105$53.3K1,989,44418.2%
Aptinyx IncCOM03836N103$36.8K2,225,09212.6%
Replimune Group Inc(REPL)COM76029N106$28.4K2,838,9689.7%
Marinus Pharmaceuticals IncCOM56854Q101$14.5K5,042,7354.9%